Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02199639
Other study ID # ibHEro
Secondary ID ibHEro
Status Recruiting
Phase N/A
First received July 23, 2014
Last updated April 29, 2015
Start date March 2014
Est. completion date December 2015

Study information

Verified date March 2014
Source Universidad Católica San Antonio de Murcia
Contact RUBÉN CUESTA-BARRIUSO, PhD
Phone 968278806
Email ruben.cuestab@gmail.com
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Observational

Clinical Trial Summary

Multidisciplinary evaluation of patients with hemophilia Spain, El Salvador and Bolivia. It aims to analyze and evaluate the skeletal muscle of patients affected with hemophilia Spain, El Salvador and Bolivia; describe deficit mobility and muscular strength, depending on the degree of injury, age, presence of inhibitors and the development of physical activity; identify the relationship between the functional deficit by clinical assessment performed with the use of validated measurement scales, the assessment of the degree of injury to specific scales of hemophilia; detect biomechanical alterations of the lower limbs and their impact on gait in patients with hemophilia; and evaluate the factors that influence the perception of illness and quality of life of patients with hemophilia.


Description:

Descriptive study of joint involvement in patients with hemophilia Spain, El Salvador and Bolivia.

Descriptive study of abnormal joint mobility and muscle strength as a result of acute conditions or the development of chronic articular sequelae.

Descriptive study of biomechanical changes in lower limb joints and their impact on gait in patients with hemophilia.

Descriptive study of the overall articular involvement (crepitus, pain, biomechanical and functional changes) in patients with hemophilia.

Descriptive study of the relationship between skeletal muscle pathology in patients with hemophilia and their perception of it, and their quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2015
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Male
Age group 6 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients with hemophilia A and B.

- Patients of all ages (pediatric, adolescents, youth and adults).

- With or without joint involvement clinically diagnosed, and with or without a previous history of hemarthrosis joint load legs.

- Patients with or without inhibitors.

Exclusion Criteria:

- Patients without prior ambulation capacity.

- Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).

- Patients with neurological or cognitive impairments that prevent understanding the questionnaires and physical tests.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Universidad Católica San Antonio de Murcia Murcia

Sponsors (1)

Lead Sponsor Collaborator
Universidad Católica San Antonio de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of range of motion of elbow, knee and ankle We will use a goniometric evaluation, along the lines indicated by Querol for assessing the range of motion in patients with hemophilia Screening visit No
Primary Assessment of muscle strength of arm, thigh and leg We will use a measure of muscular balance with the guidelines outlined by Daniels, with the adaptation of Querol for assessing muscle strength in patients with hemophilia Screening visit No
Primary Assessment of perception of joint pain We will use the visual analogue scale (VAS) for the assessment of joint pain in patients with hemophilia, with a scale from 0 (no pain) to 10 (maximum pain). Screening visit No
Primary Assessment of the status joint We will use the specific questionnaire haemophilia: Haemophilia Joint Healts Score (HJHS) for the assessment of joint status Screening visit No
Primary Evaluation of the performance of activities of daily living We will use the questionnaire Haemophilia Activities List (HAL), specific for patients with hemophilia Screening visit No
Primary Assessment of physical performance of patients with hemophilia We will use the Physical Functioning scale (HEP-Test-Q), specific for patients with hemophilia Screening visit No
Primary Assessment of personality traits of children We will use the questionnaire Eysenck Personality Questionnaire Junior (EPQJ) Screening visit No
Primary Evaluation of perceived quality of life for patients with hemophilia We will use the Hemophilia-QoL and the Child Health and Illness Profile (CHIP-CE) questionnaires for children; and the Hemophilia-QoL and A36 and 36 Health Survey (SF36) questionnairesfor adults . Screening visit No
Secondary Clinical variables of patients with hemophilia Age (years); weight (kg); Size (cm); type of haemophilia (A or B); severity of hemophilia (severe / moderate / mild); pharmacological treatment (prophylactic / on demand); presence of inhibitors; central venous catheter; family history of hemophilia; hemarthrosis in the last month; arthropathy diagnosed in some joint; use of orthoses Screening visit No
Secondary Socio-demographic variables of patients with hemophilia Number of hospital visits per year (reason); Distance to hospital (km); Academic formation of the patient (university studies / vocational training / basic studies / no studies); academic formation of the parents (university studies / vocational training / basic studies / no studies); patient employment (self-employment / employment has as an employed person / unemployed / retirement); parents employment (self-employment / employment has as an employed person / unemployed / retirement); Screening visit No
See also
  Status Clinical Trial Phase
Completed NCT02198014 - Manual Therapy in Haemophilic Arthropathy of the Knee N/A